166 related articles for article (PubMed ID: 9749494)
21. Epithelial tumor cells in bone marrow of patients with colorectal cancer: immunocytochemical detection, phenotypic characterization, and prognostic significance.
Schlimok G; Funke I; Bock B; Schweiberer B; Witte J; Riethmüller G
J Clin Oncol; 1990 May; 8(5):831-7. PubMed ID: 1692090
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation.
Fields KK; Elfenbein GJ; Trudeau WL; Perkins JB; Janssen WE; Moscinski LC
J Clin Oncol; 1996 Jun; 14(6):1868-76. PubMed ID: 8656255
[TBL] [Abstract][Full Text] [Related]
23. Immunocytochemical detection of bone marrow micrometastases in colorectal carcinoma patients, using a monoclonal antibody to villin.
Rouzier R; Bourstyn E; Grozier F; Berger A; Louvard D; Robine S
Cytometry; 2001 Oct; 46(5):281-9. PubMed ID: 11746103
[TBL] [Abstract][Full Text] [Related]
24. Detection of hematogenic tumor cell dissemination in patients undergoing resection of liver metastases of colorectal cancer.
Weitz J; Koch M; Kienle P; Schrödel A; Willeke F; Benner A; Lehnert T; Herfarth C; von Knebel Doeberitz M
Ann Surg; 2000 Jul; 232(1):66-72. PubMed ID: 10862197
[TBL] [Abstract][Full Text] [Related]
25. Tailored Systemic Therapy for Colorectal Cancer Liver Metastases.
Czauderna C; Luley K; von Bubnoff N; Marquardt JU
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769209
[TBL] [Abstract][Full Text] [Related]
26. The diagnostic values of measuring the liver volume in detecting occult hepatic metastases from colorectal cancer.
Ishizawa T; Yamamoto T; Sekikawa T
Hepatogastroenterology; 2007 Mar; 54(74):514-7. PubMed ID: 17523310
[TBL] [Abstract][Full Text] [Related]
27. Molecular cytogenetic analysis of cytokeratin 20-labeled cells in primary tumors and bone marrow aspirates from colorectal carcinoma patients.
Litle VR; Warren RS; Moore D; Pallavicini MG
Cancer; 1997 May; 79(9):1664-70. PubMed ID: 9128980
[TBL] [Abstract][Full Text] [Related]
28. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer.
Braun S; Pantel K; Müller P; Janni W; Hepp F; Kentenich CR; Gastroph S; Wischnik A; Dimpfl T; Kindermann G; Riethmüller G; Schlimok G
N Engl J Med; 2000 Feb; 342(8):525-33. PubMed ID: 10684910
[TBL] [Abstract][Full Text] [Related]
29. Management of non-resectable liver metastases from colorectal cancer.
Levitan N; Hughes KS
Oncology (Williston Park); 1990 Nov; 4(11):77-84; discussion 84, 89, 92. PubMed ID: 2150329
[TBL] [Abstract][Full Text] [Related]
30. Outcome of extensive evaluation before adjuvant therapy in women with breast cancer and 10 or more positive axillary lymph nodes.
Crump M; Goss PE; Prince M; Girouard C
J Clin Oncol; 1996 Jan; 14(1):66-9. PubMed ID: 8558222
[TBL] [Abstract][Full Text] [Related]
31. Detection of hematogenous tumor cell dissemination predicts tumor relapse in patients undergoing surgical resection of colorectal liver metastases.
Koch M; Kienle P; Hinz U; Antolovic D; Schmidt J; Herfarth C; von Knebel Doeberitz M; Weitz J
Ann Surg; 2005 Feb; 241(2):199-205. PubMed ID: 15650626
[TBL] [Abstract][Full Text] [Related]
32. Colorectal hepatic metastases: resection, local ablation, and hepatic artery infusion pump are associated with prolonged survival.
Heslin MJ; Medina-Franco H; Parker M; Vickers SM; Aldrete J; Urist MM
Arch Surg; 2001 Mar; 136(3):318-23. PubMed ID: 11231853
[TBL] [Abstract][Full Text] [Related]
33. Surgical management of hepatic metastases of colorectal cancer.
Smith JJ; D'Angelica MI
Hematol Oncol Clin North Am; 2015 Feb; 29(1):61-84. PubMed ID: 25475573
[TBL] [Abstract][Full Text] [Related]
34. Detection of disseminated tumour cells in blood and bone marrow samples of patients undergoing hepatic resection for metastasis of colorectal cancer.
Vlems FA; Diepstra JH; Punt CJ; Ligtenberg MJ; Cornelissen IM; van Krieken JH; Wobbes T; van Muijen GN; Ruers TJ
Br J Surg; 2003 Aug; 90(8):989-95. PubMed ID: 12905553
[TBL] [Abstract][Full Text] [Related]
35. Monoclonal antibody therapy with edrecolomab in breast cancer patients: monitoring of elimination of disseminated cytokeratin-positive tumor cells in bone marrow.
Braun S; Hepp F; Kentenich CR; Janni W; Pantel K; Riethmüller G; Willgeroth F; Sommer HL
Clin Cancer Res; 1999 Dec; 5(12):3999-4004. PubMed ID: 10632331
[TBL] [Abstract][Full Text] [Related]
36. [Strategy of treatment of patients with colorectal cancer with hepatic metastases].
Kalmakhelidze LG; Mosidze BA; Megrelishvili GZ
Georgian Med News; 2005 Dec; (129):19-22. PubMed ID: 16444021
[TBL] [Abstract][Full Text] [Related]
37. Micrometastases: marker of metastatic potential or evidence of residual disease?
O'Sullivan GC; Collins JK; Kelly J; Morgan J; Madden M; Shanahan F
Gut; 1997 Apr; 40(4):512-5. PubMed ID: 9176080
[TBL] [Abstract][Full Text] [Related]
38. Colorectal metastases to the liver: present status of management.
Lise M; Da Pian PP; Nitti D; Pilati PL; Prevaldi C
Dis Colon Rectum; 1990 Aug; 33(8):688-94. PubMed ID: 2165454
[TBL] [Abstract][Full Text] [Related]
39. [Micrometastases in patients with colorectal cancer: markers for metastatic potential or proofs for residual disease].
Iovchev I; Trifonov D; Popkharitov A; Khadzhipetkov F; Nikolov S
Khirurgiia (Sofiia); 2004; 60(4-5):18-21. PubMed ID: 16042058
[TBL] [Abstract][Full Text] [Related]
40. Micrometastasis in colorectal cancer: does it affect staging?
Mohajeri G; Hejab K; Sheikhbahaei S; Mohajeri M; Niknam N; Mohammadi A
ANZ J Surg; 2018 Apr; 88(4):E237-E241. PubMed ID: 27766737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
